Načítá se...
Cardiac GPCR-mediated EGFR transactivation: impact and therapeutic implications
G protein-coupled receptors (GPCR) remain primary therapeutic targets for numerous cardiovascular disorders, including heart failure (HF), due to their influence on cardiac remodeling in response to elevated neurohormone signaling. GPCR blockers have proven to be beneficial in the treatment of HF by...
Uloženo v:
| Vydáno v: | J Cardiovasc Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5516955/ https://ncbi.nlm.nih.gov/pubmed/28059858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000462 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|